"von Willebrand Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
| Descriptor ID |
D014842
|
| MeSH Number(s) |
C15.378.100.100.900 C15.378.100.141.900 C15.378.140.900 C15.378.463.920 C16.320.099.920
|
| Concept/Terms |
von Willebrand Diseases- von Willebrand Diseases
- Hemophilia, Vascular
- Vascular Hemophilia
- Vascular Hemophilias
- Vascular Pseudohemophilia
- Pseudohemophilia, Vascular
- Pseudohemophilias, Vascular
- Vascular Pseudohemophilias
- Von Willebrand's Factor Deficiency
- Von Willebrand Disorder
- Disorder, Von Willebrand
- von Willebrand's Disease
- von Willebrand's Diseases
- Angiohemophilia
- Angiohemophilias
- von Willebrand Disease
|
Below are MeSH descriptors whose meaning is more general than "von Willebrand Diseases".
Below are MeSH descriptors whose meaning is more specific than "von Willebrand Diseases".
This graph shows the total number of publications written about "von Willebrand Diseases" by people in this website by year, and whether "von Willebrand Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 17 | 2 | 19 |
| 2018 | 9 | 0 | 9 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "von Willebrand Diseases" by people in Profiles.
-
Laboratory testing for ADAMTS13: Utility for TTP diagnosis/exclusion and beyond. Am J Hematol. 2021 08 01; 96(8):1049-1055.
-
Hypercoagulopathy, acquired coagulation disorders and anticoagulation before, during and after extracorporeal membrane oxygenation in COVID-19: a case series. Perfusion. 2021 09; 36(6):592-602.
-
Etiology and Management of Bleeding during ECMO in a COVID-19 Patient. J Atheroscler Thromb. 2021 04 01; 28(4):402-403.
-
Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome. J Atheroscler Thromb. 2021 Apr 01; 28(4):396-401.
-
Registry of patients with congenital bleeding disorders and COVID-19 in Madrid. Haemophilia. 2020 Sep; 26(5):773-778.
-
Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders. Blood Transfus. 2020 09 29; 18(5):413-414.
-
Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid. Thromb Res. 2020 08; 192:2.
-
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply. J Thromb Haemost. 2019 08; 17(8):1405-1406.
-
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax. Leuk Lymphoma. 2019 12; 60(12):3078-3080.
-
[Antithrombotic treatments and inherited bleeding disorders]. Rev Med Suisse. 2018 Dec 05; 14(630):2207-2210.